Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank67
3Y CAGR+37.7%
5Y CAGR-75.2%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+37.7%/yr
Annual compound
5Y CAGR
-75.2%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 35.85% |
| 2024 | 96.30% |
| 2023 | 384.45% |
| 2022 | 13.73% |
| 2021 | -72.80% |
| 2020 | 37986.70% |
| 2019 | 99.53% |
| 2018 | -151.98% |
| 2017 | 0.00% |
| 2016 | 0.00% |